Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/12/2025

Tapering Escitalopram

Introduction to Tapering

  • All SSRIs, including escitalopram, must be slowly tapered when discontinued due to the risk of withdrawal effects, as recommended by the American Academy of Pediatrics 1, 2

Managing Withdrawal Symptoms

  • Protracted withdrawal may include dysphoria, irritability, insomnia, anhedonia, or a vague sense of being unwell that can persist for months after complete discontinuation, according to the Mayo Clinic 3
  • If intolerable symptoms occur, consider extending the time between dose reductions to 4-6 weeks, as suggested by medical guidelines 4
  • Consider smaller dose reductions (5% instead of 10%) to minimize withdrawal symptoms 4

Adjunctive Medications for Withdrawal Symptoms

  • Consider symptomatic treatments as needed, such as trazodone or mirtazapine for insomnia, NSAIDs or acetaminophen for headaches and muscle aches, and anti-nausea medications for gastrointestinal symptoms, as recommended by medical guidelines 5

Follow-Up Schedule

  • Schedule appointments every 2-4 weeks during the taper to assess for withdrawal symptoms and potential relapse, and document baseline symptoms and functioning before initiating the taper, as suggested by medical guidelines 4
  • Continue monitoring for several months after complete discontinuation for protracted withdrawal symptoms 5
  • Be prepared to adjust the tapering schedule based on individual patient response, as recommended by medical guidelines 4